Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Intangibles (2023 - 2025)

TransMedics has reported Intangibles over the past 3 years, most recently at $1.9 million for Q4 2025.

  • For Q4 2025, Intangibles fell 9.48% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $1.9 million, down 9.48%, while the annual FY2025 figure was $1.9 million, 9.48% down from the prior year.
  • Intangibles for Q4 2025 was $1.9 million at TransMedics, down from $2.0 million in the prior quarter.
  • Over five years, Intangibles peaked at $2.4 million in Q3 2023 and troughed at $1.9 million in Q4 2025.
  • A 3-year average of $2.2 million and a median of $2.2 million in 2024 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: decreased 8.44% in 2024 and later dropped 9.48% in 2025.
  • Year by year, Intangibles stood at $2.4 million in 2023, then fell by 8.58% to $2.2 million in 2024, then dropped by 9.48% to $1.9 million in 2025.
  • Business Quant data shows Intangibles for TMDX at $1.9 million in Q4 2025, $2.0 million in Q3 2025, and $2.0 million in Q2 2025.